Growth Metrics

Cannabis Suisse (CSUI) EBIAT (2016 - 2025)

Cannabis Suisse (CSUI) has disclosed EBIAT for 10 consecutive years, with $22392.0 as the latest value for Q4 2025.

  • On a quarterly basis, EBIAT rose 342.35% to $22392.0 in Q4 2025 year-over-year; TTM through Nov 2025 was $110181.0, a 106.9% increase, with the full-year FY2025 number at -$456142.0, up 61.56% from a year prior.
  • EBIAT was $22392.0 for Q4 2025 at Cannabis Suisse, up from $13907.0 in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $332474.0 in Q4 2021 to a low of -$999085.0 in Q2 2024.
  • A 5-year average of -$106874.0 and a median of -$59777.0 in 2023 define the central range for EBIAT.
  • Peak YoY movement for EBIAT: crashed 1386.38% in 2024, then skyrocketed 342.35% in 2025.
  • Cannabis Suisse's EBIAT stood at $332474.0 in 2021, then plummeted by 109.04% to -$30050.0 in 2022, then tumbled by 82.35% to -$54797.0 in 2023, then surged by 109.24% to $5062.0 in 2024, then surged by 342.35% to $22392.0 in 2025.
  • Per Business Quant, the three most recent readings for CSUI's EBIAT are $22392.0 (Q4 2025), $13907.0 (Q3 2025), and $44367.0 (Q2 2025).